Cytoki Pharma ApS

CVR 40594132 · Private limited company (ApS) · In voluntary liquidation

Cytoki Pharma ApS is a Private limited company (ApS), founded on , based in Søborg. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is no longer active (status: in voluntary liquidation). 7 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 13.5m and a net result of DKK -43.8m.

Company details

CVR number
40594132
Status
In voluntary liquidation
Company type
Private limited company (ApS)
Founded
Address
Vandtårnsvej 77
2860 Søborg
Municipality
Gladsaxe
Industry
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Share capital
DKK 357k
Auditor
PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
Audit opted out
No

Warning signs

Annual reports filed late1 of 7
Missing annual reportNo
Negative equityNo
Equity ratio75.0%
Current ratio397%
Moves (last 2 years)0
CEO changes in total0
CEO's previous bankruptcies0
Other companies at the address76
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK -42.2mDKK -39.1m
Net profitDKK -43.8mDKK -39.3m
EquityDKK 13.5mDKK 57.3m
Total assetsDKK 18.0mDKK 62.9m
CashDKK 11.8m–
Short-term debtDKK 4.5m–
Avg. employees4–

Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Jan 2025 – 31 Dec 202598
1 Jan 2024 – 31 Dec 202483
1 Jan 2023 – 31 Dec 202381
1 Jan 2022 – 31 Dec 2022153
1 Jan 2021 – 31 Dec 202196
1 Jan 2020 – 31 Dec 2020182
12 Jun 2019 – 31 Dec 2019244 Late

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
BoardRasmus Jørgensen
BoardSusanne Jørgensen
BoardChristian Ellebæk Elling
BoardKaren Ina Barbara Wagner
BoardAmanda Viven Gett-Chaperot
BoardDaniel Bach Gonzalez
BoardAnnegret Elisabeth De Baey-Diepolder
BoardKlaus Andreas Dugi
Owner (25%)LUNDBECKFOND INVEST A/SCurrent
Owner (5%)Health For Life Capital II Prima S.C.A. RAIFCurrent
Owner (5%)Health for Life Capital II FPCI - ALPHA CompartmentCurrent
Owner (10%)15-Bio ApSCurrent
Owner (15%)YSIOS Biofund III, F.C.R.ECurrent
Owner (20%)NanoDimension III, L.PCurrent
Owner (5%)FCPI Bio Sante 2018-2019Current
Owner (100%)15-Bio ApS
Owner (20%)15-Bio ApS
Owner (10%)YSIOS Biofund III, F.C.R.E
Owner (10%)NanoDimension III, L.P
Owner (15%)NanoDimension III, L.P
Owner (5%)FCPI Bio Sante 2018-2019
Owner (15%)15-Bio ApS
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKABCurrent
AuditorEY Godkendt Revisionspartnerselskab
Founder15-Bio ApSCurrent

Address history (3 moves)

Vandtårnsvej 77, 2860 Søborg
Tuborg Boulevard 12, 3., 2900 Hellerup
Lejrvej 19, 1., 3500 Værløse
c/o Rasmus Jørgensen, Enebærhaven 9, 3500 Værløse

Former names

Cytoki Pharma ApS – now
CytoKi Pharma ApS –

Other companies at the same address

Similar companies in Gladsaxe

Questions and answers about Cytoki Pharma ApS

Has Cytoki Pharma ApS gone bankrupt?

No, Cytoki Pharma ApS is not registered as bankrupt in the CVR register. Its status is: in voluntary liquidation.

Who is the auditor of Cytoki Pharma ApS?

Cytoki Pharma ApS most recently used PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB.

When was Cytoki Pharma ApS founded?

Cytoki Pharma ApS was founded on 12 June 2019.

What is the equity of Cytoki Pharma ApS?

Equity was DKK 13.5m according to the annual report for the period ending 31 December 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.